Tapewire

Nasdaq · USD

RYTM

RHYTHM PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3693
SEC CIK
0001649904
Parsed reports
430

Last 12 months

Inside the activity.

0 purchase rows · 50 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 202501
Jan 202600
Feb 2026023
Mar 202601
Apr 202600
May 202601
Jun 202601
Jul 202600
Aug 2026015
Sep 202605
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 16, 2024 Filed Feb 22, 2024 00:03 UTC
Meeker David PDirector · President and CEO
GrantCommon Stock 99,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-026162 · tm246920-7_4seq1.xml · nonDerivative · entry 1

Meeker David P · CIK 0001385155 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 220,099

F1 · shares: The Issuer previously granted the Reporting Person an award of restricted stock units that vest based on the Issuer's satisfaction of certain performance objectives. On February 16, 2024, the Board determined that the performance condition had been satisfied.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 00:01 UTC
Smith Hunter CChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 80,400 $0.00 Strike: $49.23 $0.00
Disclosure

SEC source: 0001104659-24-026156 · tm246920-3_4seq1.xml · derivative · entry 3

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,400

Underlying: Common Stock · 80,400 shares

Expires 2034-02-15

F4 · derivative.exercise_date: The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 00:01 UTC
Smith Hunter CChief Financial Officer
GrantRestricted Stock Units · Derivative 26,400 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-026156 · tm246920-3_4seq1.xml · derivative · entry 2

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,400

Underlying: Common Stock · 26,400 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 00:01 UTC
Smith Hunter CChief Financial Officer
GrantCommon Stock 33,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-026156 · tm246920-3_4seq1.xml · nonDerivative · entry 1

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,454

F1 · shares: The Issuer previously granted the Reporting Person an award of restricted stock units that vest based on the Issuer's satisfaction of certain performance objectives. On February 16, 2024, the Board determined that the performance condition had been satisfied.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 00:02 UTC
Mazabraud YannEVP, Head of International
GrantStock Option (Right to Buy) · Derivative 67,000 $0.00 Strike: $49.23 $0.00
Disclosure

SEC source: 0001104659-24-026160 · tm246920d6_4seq1.xml · derivative · entry 3

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 67,000

Underlying: Common Stock · 67,000 shares

Expires 2034-02-15

F4 · derivative.exercise_date: The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 00:02 UTC
Mazabraud YannEVP, Head of International
GrantRestricted Stock Units · Derivative 22,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-026160 · tm246920d6_4seq1.xml · derivative · entry 2

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Stock · 22,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 00:02 UTC
Mazabraud YannEVP, Head of International
GrantCommon Stock 33,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-026160 · tm246920d6_4seq1.xml · nonDerivative · entry 1

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,495

F1 · shares: The Issuer previously granted the Reporting Person an award of restricted stock units that vest based on the Issuer's satisfaction of certain performance objectives. On February 16, 2024, the Board determined that the performance condition had been satisfied.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 00:00 UTC
Shulman JosephChief Technical Officer
GrantStock Option (Right to Buy) · Derivative 50,250 $0.00 Strike: $49.23 $0.00
Disclosure

SEC source: 0001104659-24-026155 · tm246920-2_4seq1.xml · derivative · entry 3

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,250

Underlying: Common Stock · 50,250 shares

Expires 2034-02-15

F4 · derivative.exercise_date: The stock options were granted on February 16, 2024. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 00:00 UTC
Shulman JosephChief Technical Officer
GrantRestricted Stock Units · Derivative 16,500 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-026155 · tm246920-2_4seq1.xml · derivative · entry 2

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,500

Underlying: Common Stock · 16,500 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Read SEC document
February 16, 2024 Filed Feb 22, 2024 00:00 UTC
Shulman JosephChief Technical Officer
GrantCommon Stock 33,750 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-026155 · tm246920-2_4seq1.xml · nonDerivative · entry 1

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,780

F1 · shares: The Issuer previously granted the Reporting Person an award of restricted stock units that vest based on the Issuer's satisfaction of certain performance objectives. On February 16, 2024, the Board determined that the performance condition had been satisfied.

Read SEC document
February 14, 2024 Filed Feb 15, 2024 23:14 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 1,089 $50.01 $54,460.89
Disclosure

SEC source: 0001104659-24-024605 · tm246165-6_4seq1.xml · nonDerivative · entry 2

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 5, 2023.

Read SEC document
February 13, 2024 Filed Feb 14, 2024 01:47 UTC
Lee Jennifer KaydenEVP, Head of North America
SaleCommon Stock 615 $49.83 $30,645.45
Disclosure

SEC source: 0001104659-24-022538 · tm246165-3_4seq1.xml · nonDerivative · entry 4

Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,852

F2 · kind: The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 13, 2024 Filed Feb 14, 2024 01:50 UTC
Smith Hunter CChief Financial Officer
SaleCommon Stock 709 $49.82 $35,322.38
Disclosure

SEC source: 0001104659-24-022540 · tm246165-5_4seq1.xml · nonDerivative · entry 4

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,704

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 13, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 473 $49.84 $23,574.32
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · nonDerivative · entry 9

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,984

F3 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 13, 2024 Filed Feb 14, 2024 01:49 UTC
Mazabraud YannEVP, Head of International
SaleCommon Stock 957 $49.84 $47,696.88
Disclosure

SEC source: 0001104659-24-022539 · tm246165-4_4seq1.xml · nonDerivative · entry 4

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,745

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 13, 2024 Filed Feb 15, 2024 23:14 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 1,865 $50.00 $93,250.00
Disclosure

SEC source: 0001104659-24-024605 · tm246165-6_4seq1.xml · nonDerivative · entry 1

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,119

F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 5, 2023.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 01:45 UTC
Cramer Pamela J.Chief Human Resources Officer
SaleCommon Stock 696 $51.38 $35,760.48
Disclosure

SEC source: 0001104659-24-022536 · tm246165-1_4seq1.xml · nonDerivative · entry 2

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,770

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 01:47 UTC
Lee Jennifer KaydenEVP, Head of North America
SaleCommon Stock 1,023 $51.38 $52,561.74
Disclosure

SEC source: 0001104659-24-022538 · tm246165-3_4seq1.xml · nonDerivative · entry 3

Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,467

F2 · kind: The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 01:50 UTC
Smith Hunter CChief Financial Officer
SaleCommon Stock 1,209 $51.38 $62,118.42
Disclosure

SEC source: 0001104659-24-022540 · tm246165-5_4seq1.xml · nonDerivative · entry 3

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,413

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 791 $51.38 $40,641.58
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · nonDerivative · entry 8

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,457

F3 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 12, 2024 Filed Feb 14, 2024 01:49 UTC
Mazabraud YannEVP, Head of International
SaleCommon Stock 1,594 $51.38 $81,899.72
Disclosure

SEC source: 0001104659-24-022539 · tm246165-4_4seq1.xml · nonDerivative · entry 3

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,702

F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Read SEC document
February 11, 2024 Filed Feb 14, 2024 01:47 UTC
Lee Jennifer KaydenEVP, Head of North America
Exercise / conversionRestricted Stock Units · Derivative 2,031 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-022538 · tm246165-3_4seq1.xml · derivative · entry 6

Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,031

Underlying: Common Stock · 2,031 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.

F4 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.

Read SEC document
February 11, 2024 Filed Feb 14, 2024 01:47 UTC
Lee Jennifer KaydenEVP, Head of North America
Exercise / conversionCommon Stock 2,031 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-022538 · tm246165-3_4seq1.xml · nonDerivative · entry 2

Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,490

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 11, 2024 Filed Feb 14, 2024 01:50 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 2,344 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-022540 · tm246165-5_4seq1.xml · derivative · entry 6

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,343

Underlying: Common Stock · 2,344 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.

F4 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.

Read SEC document
February 11, 2024 Filed Feb 14, 2024 01:50 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionCommon Stock 2,344 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-022540 · tm246165-5_4seq1.xml · nonDerivative · entry 2

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,622

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 11, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
Exercise / conversionRestricted Stock Units · Derivative 1,562 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · derivative · entry 12

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,562

Underlying: Common Stock · 1,562 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F8 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.

F8 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.

Read SEC document
February 11, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
Exercise / conversionCommon Stock 1,562 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · nonDerivative · entry 7

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,248

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 11, 2024 Filed Feb 14, 2024 01:49 UTC
Mazabraud YannEVP, Head of International
Exercise / conversionRestricted Stock Units · Derivative 2,031 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-022539 · tm246165-4_4seq1.xml · derivative · entry 6

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,031

Underlying: Common Stock · 2,031 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F4 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.

F4 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date.

Read SEC document
February 11, 2024 Filed Feb 14, 2024 01:49 UTC
Mazabraud YannEVP, Head of International
Exercise / conversionCommon Stock 2,031 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-022539 · tm246165-4_4seq1.xml · nonDerivative · entry 2

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,296

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:45 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionRestricted Stock Units · Derivative 2,344 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-022536 · tm246165-1_4seq1.xml · derivative · entry 3

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,687

Underlying: Common Stock · 2,344 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:45 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionCommon Stock 2,344 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-022536 · tm246165-1_4seq1.xml · nonDerivative · entry 1

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,466

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:47 UTC
Lee Jennifer KaydenEVP, Head of North America
Exercise / conversionRestricted Stock Units · Derivative 3,438 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-022538 · tm246165-3_4seq1.xml · derivative · entry 5

Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,874

Underlying: Common Stock · 3,438 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:47 UTC
Lee Jennifer KaydenEVP, Head of North America
Exercise / conversionCommon Stock 3,438 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-022538 · tm246165-3_4seq1.xml · nonDerivative · entry 1

Lee Jennifer Kayden · CIK 0001801372 · EVP, Head of North America

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,459

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:50 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 4,063 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-022540 · tm246165-5_4seq1.xml · derivative · entry 5

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,124

Underlying: Common Stock · 4,063 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:50 UTC
Smith Hunter CChief Financial Officer
Exercise / conversionCommon Stock 4,063 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-022540 · tm246165-5_4seq1.xml · nonDerivative · entry 1

Smith Hunter C · CIK 0001636385 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,278

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
Exercise / conversionStock Option (right to buy) · Derivative 69,190 $0.00 Strike: $21.38 $0.00
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · derivative · entry 11

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,610

Underlying: Common Stock · 69,190 shares

Expires 2030-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The stock options were granted on July 27, 2020. 25% of the shares subject to the option vested and became exercisable on July 27, 2021 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
Exercise / conversionRestricted Stock Units · Derivative 2,656 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · derivative · entry 10

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,312

Underlying: Common Stock · 2,656 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F6 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

F6 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 100 $51.52 $5,152.00
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · nonDerivative · entry 6

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,686

F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 5, 2023.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 23,397 $50.88 $1,190,502.53
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · nonDerivative · entry 5

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,786

F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 5, 2023.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $50.47 to $51.43. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 48,177 $50.14 $2,415,503.24
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · nonDerivative · entry 4

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,183

F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 5, 2023.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $49.47 to $50.46. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
SaleCommon Stock 100 $48.24 $4,824.00
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · nonDerivative · entry 3

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,360

F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 5, 2023.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
Exercise / conversionCommon Stock 69,190 $21.38 $1,479,282.20
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · nonDerivative · entry 2

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,460

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:46 UTC
Shulman JosephChief Technical Officer
Exercise / conversionCommon Stock 2,656 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-022537 · tm246165-2_4seq1.xml · nonDerivative · entry 1

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,270

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:49 UTC
Mazabraud YannEVP, Head of International
Exercise / conversionRestricted Stock Units · Derivative 3,438 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-022539 · tm246165-4_4seq1.xml · derivative · entry 5

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,874

Underlying: Common Stock · 3,438 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 9, 2023, February 9, 2024, February 9, 2025 and February 9, 2026. The restricted stock units have no expiration date.

Read SEC document
February 09, 2024 Filed Feb 14, 2024 01:49 UTC
Mazabraud YannEVP, Head of International
Exercise / conversionCommon Stock 3,438 Not disclosed Not disclosed
Disclosure

SEC source: 0001104659-24-022539 · tm246165-4_4seq1.xml · nonDerivative · entry 1

Mazabraud Yann · CIK 0001774702 · EVP, Head of International

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,265

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Read SEC document
February 09, 2024 Filed Nov 14, 2024 02:01 UTC Amendment
Shulman JosephChief Technical Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,985 $0.00 Strike: $6.80 $0.00
Disclosure

SEC source: 0001104659-24-117940 · tm2428383-2_4aseq1.xml · derivative · entry 4

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,875

Underlying: Common Stock · 3,985 shares

Expires 2022-02-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This amendment is being filed to correct the number of options exercised in row two of each of Table I and Table II in the originally filed Form 4 on February 13, 2024; and to report the exercise of the options in row two of each of Table I and Table II in this amended Form 4. The originally filed Form 4 reported 69,190 options exercised in row two of each of Table 1 and Table II which should have been 69,160, the total amount actually exercised.

F3 · derivative.exercise_date: The stock options were granted on February 9, 2022. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.

Read SEC document
February 09, 2024 Filed Nov 14, 2024 02:01 UTC Amendment
Shulman JosephChief Technical Officer
Exercise / conversionStock Option (right to buy) · Derivative 65,175 $0.00 Strike: $21.38 $0.00
Disclosure

SEC source: 0001104659-24-117940 · tm2428383-2_4aseq1.xml · derivative · entry 3

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,625

Underlying: Common Stock · 65,175 shares

Expires 2030-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This amendment is being filed to correct the number of options exercised in row two of each of Table I and Table II in the originally filed Form 4 on February 13, 2024; and to report the exercise of the options in row two of each of Table I and Table II in this amended Form 4. The originally filed Form 4 reported 69,190 options exercised in row two of each of Table 1 and Table II which should have been 69,160, the total amount actually exercised.

F2 · derivative.exercise_date: The stock options were granted on July 27, 2020. 25% of the shares subject to the option vested and became exercisable on July 27, 2021 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter.

Read SEC document
February 09, 2024 Filed Nov 14, 2024 02:01 UTC Amendment
Shulman JosephChief Technical Officer
Exercise / conversionCommon Stock 3,985 $6.80 $27,098.00
Disclosure

SEC source: 0001104659-24-117940 · tm2428383-2_4aseq1.xml · nonDerivative · entry 2

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 74,430

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This amendment is being filed to correct the number of options exercised in row two of each of Table I and Table II in the originally filed Form 4 on February 13, 2024; and to report the exercise of the options in row two of each of Table I and Table II in this amended Form 4. The originally filed Form 4 reported 69,190 options exercised in row two of each of Table 1 and Table II which should have been 69,160, the total amount actually exercised.

Read SEC document
February 09, 2024 Filed Nov 14, 2024 02:01 UTC Amendment
Shulman JosephChief Technical Officer
Exercise / conversionCommon Stock 65,175 $21.38 $1,393,441.50
Disclosure

SEC source: 0001104659-24-117940 · tm2428383-2_4aseq1.xml · nonDerivative · entry 1

Shulman Joseph · CIK 0001909855 · Chief Technical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 70,415

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This amendment is being filed to correct the number of options exercised in row two of each of Table I and Table II in the originally filed Form 4 on February 13, 2024; and to report the exercise of the options in row two of each of Table I and Table II in this amended Form 4. The originally filed Form 4 reported 69,190 options exercised in row two of each of Table 1 and Table II which should have been 69,160, the total amount actually exercised.

Read SEC document
February 01, 2024 Filed Feb 5, 2024 23:53 UTC
Cramer Pamela J.Chief Human Resources Officer
Exercise / conversionRestricted Stock Units · Derivative 2,650 $0.00 $0.00
Disclosure

SEC source: 0001104659-24-010796 · tm245251-1_4seq1.xml · derivative · entry 3

Cramer Pamela J. · CIK 0001873517 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,950

Underlying: Common Stock · 2,650 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F3 · derivative.exercise_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date.

F3 · derivative.expiration_date: The restricted stock units vest or have vested as to 25% of the total shares on each of February 1, 2024, February 1, 2025, February 1, 2026 and February 1, 2027. The restricted stock units have no expiration date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.